期刊文献+

腹腔连续注射低剂量氯胺酮后大鼠海马LC3和Beclin1的表达 被引量:4

Expression of LC3 and Beclin1 in rat hippocampus after repeated intraperitoneal administration of low dose of ketamine
原文传递
导出
摘要 目的研究腹腔连续注射低剂量氯胺酮后大鼠海马自噬相关蛋白LC3、Beclin1的表达及其意义。方法 SD大鼠30只随机分为用药组和对照组,用药组大鼠以5mg/kg的剂量腹腔注射氯胺酮,每间隔30min 1次,共5次。对照组予以等量生理盐水。用药组大鼠按用药后时间不同分为6小组,分别于末次给药后1,3,6,12,24,48h后取海马组织备用,用免疫荧光技术和Western blot技术检测大鼠海马组织中LC3、Beclin1的表达,应用统计学处理,比较用药组与对照组的蛋白表达差异。结果与对照组比较,用药组大鼠海马组织中LC3Ⅱ/LC3Ⅰ值在1h表达开始增多,6h呈强表达,Beclinl的表达在6h开始增多,12,24,48h都呈强表达(P<0.05)。结论腹腔连续注射低剂量氯胺酮能促进海马组织发生自噬,自噬增强是对氯胺酮毒性的反应。 Objective To investigate expression of autophagic protein LC3 and Beclinl in the rat hippoeampus after repeated intraperitoneal injection of low dose of ketamine (Ket). Methods 30 SD rats were randomly divided into ket group and control group. Ketamine was administered intraperitoneally at 5mg/kg every 30 min for 5 times in Ket group. Equal volume of 0. 9% saline was given intraperitoneally to the control rats. Rat hippocampuses were collected at 1,3, 6, 12, 24 and 48h after last administration. LC3 and Beclinl were examined by immunofluorescent staining and Western blot. The ratio of LC3 Ⅱ/LC3 Ⅰ was evaluated. Expression difference was analyzed between ketamine group and control group by statistical analysis. Results The ratio of LC311/LC3Istarted to increase lh after Ket administration and peaked at 6h. The level of Beclinl was elevated at 6h after Ket administration, which was strongly expressed up to 48h. Conclusion It is suggested that upgraded autophagy may occur in rat hippoeampus after repeated administration of low dose of ketarnine, presenting a toxic reaction to ketamine.
出处 《中国法医学杂志》 CSCD 2012年第2期101-104,共4页 Chinese Journal of Forensic Medicine
关键词 法医毒理学 氯胺酮 自噬 LC3 BECLIN1 forensic toxicology ketamine autophagy LC3 Beclin 1
  • 相关文献

参考文献4

二级参考文献52

  • 1张帆,李静.氯胺酮滥用合并焦虑障碍一例[J].中国药物依赖性杂志,2005,14(1):23-23. 被引量:1
  • 2刘志民,李密,曹家琪,孙文林,孙桂宽,吕宪祥,赵成正,赵苳,蔡志基.赤峰市部分地区阿片滥用者流行学调查[J].中国药物依赖性通报,1992,1(2):83-87. 被引量:7
  • 3Zarate CA Jr,Singh JB,Carlson PJ,et al.A randomized trim of an N-methyl-D-aspartate antagonist in treatment-resistant major depression[J].Arch Gen Psychiatry,2006,63 (8):856-864.
  • 4Corlett PR,Honey GD,Fletcher PC.From prediction error to psychosis:ketamine as a pharmacological model of delusions[J].J Psychopharmacol,2007,21 (3):238-252.
  • 5Morgan CJ,Rossell SL,Pepper F,et al.Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users[J].Biol Psychiatry,2006,59(3):265-272.
  • 6Lira DK.Ketamine associated psychedelic effects and dependence[J].Singapore Med J,2003,44(1):31-34.
  • 7Trujillo KA,Zamora JJ,Warmoth KP.Increased response to ketamine following treatment at long intervals:implications for intermittent use[J].Biol Psychiatry,2008,63 (2):178-183.
  • 8van der Kam EL,de Vry J,Tzschentke TM.Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat[J].Behav Pharmacol,2007,18(8):717-724.
  • 9Suzuki T,Kato H,Aoki T,et al.Effects of the noncompetitive NMDA receptor antagonist ketamine on morphine-induced place preference in mice[J].Life Sci,2000,67(4):383-389.
  • 10Vorel SR,Liu X,Hayes R J,et al.Relapse to cocaine-seeking after hippocampal theta burst stimulation[J].Science,2001,292(5519):1175-1178.

共引文献57

同被引文献51

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部